LONDON, February 1, 2013 /PRNewswire/ --
Visiongain's analysis predicts the medical device contract manufacturing market to be worth $119.5bn by 2023. The market generated $33.6bn in 2011, according to Medical Device Contract Manufacturing: World Market Outlook 2013-2023, published in January 2013. With increased pricing pressures particularly in developed countries, the survival tool for the medical device manufacturers is to cut costs.
Amritha.M.Ramakrishnan, healthcare industry analyst says "The contract manufacturing market is witnessing higher growth than the overall medical device industry, which is driven by an increasing aging population and demand for more innovative devices. As companies struggle to reduce costs and remain competitive, the opportunities for contract manufacturers are enormous. Outsourcing is now widely accepted among medical device companies due to the benefits it offers like speed to market, reduced cost, quality improvement and availability of highly skilled labor. Rather than looking at contract manufacturers as a separate entity, OEMs now view outsourcing as a necessity to improve their overall quality and reduce expenditure."
Currently, the medical device contract manufacturing industry is highly fragmented with several thousand companies providing a range of services. It is expected that there will be major consolidations in the future as CMOs seek to provide increased operational capabilities. Major companies operating in this space include Accellent, Flextronics, Symmetry medical, The Tech Group, Greatbatch and Nortech systems. However, the level of medical device outsourcing is still low as compared to other industries such as pharmaceutical, automotive and electronics due to late entry of the medical device industry in to the outsourcing market, in addition to concerns over quality and regulatory compliance.
Developed markets such as the US and Western Europe still continue to dominate the medical device contract manufacturing market. However, fastest growing markets include Asian countries like China and India where OEMs can take advantage of reduced cost and highly skilled labor. This trend also gives OEMs an opportunity to enter these markets. The future may see the advent of virtual medical device manufacturers, who may outsource all their operations to contract manufacturing organisations, and work without any physical manufacturing plants.
For further information concerning the Visiongain's Medical Device Contract Manufacturing: World Market Outlook 2013-2023 report please visit: http://www.visiongain.com/Report/970/Medical-Device-Contract-Manufacturing-World-Market-Outlook-2013-2023
Email: Sara Peerun on firstname.lastname@example.org
Advanced Moulding Technologies
Boston Biomedical Associates
Centre for Devices and Radiological Health (CDRH)
Cirtech Medical Systems
Electrolyzing Corporation of Ohio
Food and Drug Administration (FDA)
Forefront Medical Technology
International Organization for Standardization (ISO)
Johnson & Johnson
Kimball Electronics Group
National Health Service (NHS)
Olympus Medical Systems
Smith & Nephew
St. Jude Medical
State Food and Drug Administration
The Tech Group
Toshiba Medical Systems
Notes for Editors
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-2-business conferences, newsletters, management reports and e-zines focusing on the Energy, Telecoms, Pharmaceutical, Defence, Materials sectors.
Visiongain publishes reports produced by its in-house analysts, who are qualified experts in their field. Visiongain has firmly established itself as the first port-of-call for the business professional, who needs independent, high quality, original material to rely and depend on.
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44(0)207-336-6100